Home
Invivyd, Inc.

Invivyd, Inc. Market Share Analysis for August 2026

Invivyd is on a mission to rapidly and continually deliver antibody-based therapies that keep pace with the evolving viral threats

Health > Biotechnology and Pharmaceuticals

Domaininvivyd.com

Year Founded2020

Employees51 - 200

Annual Revenue$50M - $75M

Invivyd, Inc.

Invivyd, Inc. (including company regionals)

invivyd.com

See more website traffic and engagement information

Invivyd, Inc. Revenue up to August 2026 is 50M - 75M

revenue generated by Invivyd, Inc. top domains

Invivyd, Inc. top domains revenue over 3 years

Revenue for Invivyd, Inc. top domains

invivyd.com50M - 75M

See more with Sales Intelligence

Total visits to Invivyd, Inc.'s top domains

Understand Invivyd, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

invivyd.com12.6K

See more with Sales Intelligence

Avg. visit duration in Invivyd, Inc.'s top domains

Analyze Invivyd, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

invivyd.com00:02:36

See more with Sales Intelligence

Avg. pageviews on Invivyd, Inc.'s top domains

See how Invivyd, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

invivyd.com2.10

See more with Sales Intelligence

Invivyd, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

biocentury.comCompany NameBioCenturyEmployees51 - 200HQUnited States, California, Redwood CityAnnual revenue$15M - $25MTotal visits34.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Invivyd, Inc.

These are the website technologies, by industry, used by Invivyd, Inc. top domains

Payment & Currencies (10)

Cart Functionality

eCommerce (5)

OpenCart

Conversion & Analytics (3)

Google Analytics

Cryptocurrency (3)

Bitcoin Acceptance

More Technologies

11

See all

News & Signals from Invivyd, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInvivyd, Inc. promoted Marc Elia to chief executive on Sep 3rd '26.Connecticut-based Invivyd (Nasdaq: IVVD), a biopharma focused on protection from serious viral infectious diseases, has appointed Marc Elia (pictured above), current chairman of its board, as chief executive.

NewsInvivyd, Inc. hires Ajay Royan as lead independent director.Invivyd also named Ajay Royan, founder of Mithril Capital and an early company investor, lead independent director.